Vistos Co., Ltd
Financials
Valuation Metrics
Vistos Co., Ltd's Market Cap is ₩189B. At end of 2025 it was ₩319B. Ranked #2355 of 2,421 in KR market (top 97%), #1582 of 1,640 on KOSDAQ (top 96%), #93 of 96 in Health Care Equipment & Services (top 97%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 18.89B KRW | KR#2,355/2,421 Sec#93/96 |
| Revenue | 16.08B KRW | KR#2,201/2,421 Sec#75/96 |
| Net Income | -1.01B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 29.85B KRW | KR#2,338/2,421 Sec#88/96 |
| Net Assets | 19.78B KRW | KR#2,289/2,421 Sec#86/96 |
| Employees | 69 | KR#1,887/2,421 Sec#76/96 |
| Value | ||
| P/B | 0.95x | KR#1,424/2,421 Sec#37/96 |
| P/S | 1.17x | KR#1,491/2,421 Sec#37/96 |
| FCF Yield | -11.69% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -5.10% | KR#1,803/2,421 Sec#61/96 |
| ROA | -3.38% | KR#1,855/2,421 Sec#62/96 |
| Op. Margin | -11.02% | KR#2,015/2,421 Sec#64/96 |
| Revenue Growth | -12.01% | KR#1,969/2,421 Sec#82/96 |
| Financial Health | ||
| Debt Ratio | 50.95% | KR#972/2,421 Sec#55/96 |
| Total Debt | 4.70B KRW | KR#1,806/2,421 Sec#67/96 |
| FCF | -2.21B KRW | KR#1,352/2,421 Sec#42/96 |
| Cash | 8.27B KRW | KR#1,797/2,421 Sec#59/96 |
| Current Ratio | 2.56x | KR#671/2,421 Sec#39/96 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,421 Sec—/96 |
| Performance | ||
| 1Y Return | -49.68% | KR#2,054/2,421 Sec#69/96 |
| 1M Return | -10.83% | KR#2,130/2,421 Sec#79/96 |
| From 52W High | -72.43% | KR#2,247/2,421 Sec#87/96 |
| 1Y MDD | -78.67% | KR#2,273/2,421 Sec#89/96 |
| Trading | ||
| Volume | 6,495 shares | KR#2,058/2,421 Sec#85/96 |
| Trading Value | 20.6M KRW | KR#2,134/2,421 Sec#83/96 |
| Foreign Own. | 0.00% | KR—/2,421 Sec—/96 |
| Per Share | ||
| EPS | -169 KRW | KR—/2,421 Sec—/96 |
| BPS | 3,319 KRW | KR#1,789/2,421 Sec#50/96 |
Company Info
Bistos, established in 2001, specializes in manufacturing medical devices, particularly for fetal and neonatal care, including fetal monitors, jaundice therapy devices, and incubators, and was listed on KOSDAQ in 2022. Over 90% of its sales come from exports to over 120 countries. The company is expanding into home medical devices like breast pumps and thermometers, patient monitors, and aims to become a leader in biosignal technology by exploring ADHD/dementia treatment and wearable healthcare. Bistos is headquartered in Gyeonggi-do, Seongnam-si.